Drug-Resistant Tuberculosis (DR-TB)
Drug-Resistant Tuberculosis (DR-TB) occurs when Mycobacterium tuberculosis becomes resistant to one or more first-line anti-TB drugs.
This resistance develops due to irregular treatment, incomplete therapy, or improper drug use.
DR-TB is harder to treat and often requires stronger second-line medications with longer treatment duration.
Symptoms are similar to regular TB—cough, fever, weight loss, and night sweats—but treatment response is slower.
Early diagnosis through drug-susceptibility testing (DST) and strict adherence to therapy is essential to prevent further resistance.
Drug-Resistant Tuberculosis (DR-TB) Read Post »









